# Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial

> **NCT07542418** · NA · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 204 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Thiotepa and Melphalan
- **OTHER:** Melphalan

## Key facts

- **NCT ID:** NCT07542418
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2028-04-20
- **Final completion:** 2028-10-20
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542418, "Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07542418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*